Evernest Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
576
+84
| +17% | +$34.1K | 0.08% | 154 |
|
|
2025
Q1 | $245K | Sell |
492
-29
| -6% | -$14.4K | 0.09% | 140 |
|
|
2024
Q4 | $271K | Buy |
521
+20
| +4% | +$10.4K | 0.07% | 138 |
|
|
2024
Q3 | $310K | Sell |
501
-65
| -11% | -$40.2K | 0.08% | 131 |
|
|
2024
Q2 | $313K | Buy |
566
+1
| +0.2% | +$553 | 0.14% | 101 |
|
|
2024
Q1 | $308K | Buy |
565
+83
| +17% | +$45.2K | 0.15% | 103 |
|
|
2023
Q4 | $256K | Buy |
+482
| New | +$256K | 0.13% | 114 |
|
|
2021
Q4 | $265K | Buy |
+482
| New | +$265K | 0.14% | 109 |
|